Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,697.50
Bid: 1,697.00
Ask: 1,698.00
Change: -7.50 (-0.44%)
Spread: 1.00 (0.059%)
Open: 1,705.00
High: 1,711.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Traders bide their time ahead of US jobs data

Mon, 28th Jul 2014 17:26

- BskyB paces gains- Lloyds fined $370m by UK and US authorities- Aberdeen Asset Management sees slight drop in AuMtechMARK 2,776.05 -0.83%FTSE 100 6,788.07 -0.05%FTSE 250 15,616.53 -0.48%The Footsie finished the session slightly lower as traders bided their time ahead of a raft of key data and events later in the week, including the latest US jobs report and a Federal Reserve policy meeting, on Wednesday. Acting as a backdrop, traders continued to closely monitor the worsening security situation in the Gaza strip and Ukraine.That came as US President Barack Obama was scheduled to speak on Monday with several European leaders concerning the crisis in the latter country, with markets eyeing the possibility of further European sanctions against the Russian Federation. The top flight index ended the day 3.48 points below Friday's close of 6,791.55. Financials led on the downside, with Aberdeen Asset Management heading up the fallers. In parallel, RBS gave back some of last Friday's sharp gains after it released its better than expected results ahead of schedule. Of note, Lloyds' share price was hit by news that it had agreed to pay $370m in fines to US and UK authorities.Pending home sales Stateside dropped 1.1% from a month earlier after rising 6% in May, according to the National Association of Realtors. Analysts had forecast a rise of 0.5%.BskyB tops leaderboard Back in the UK, British Sky Broadcasting topped the leaderboard. On Friday the company announced a deal to acquire 21st Century Fox's holdings in Sky Italia and Sky Deutschland. Reckitt Benkiser said that it expects market conditions to remain challenging in the second half of the year, particularly in the US and certain emerging markets, but that it was still on track to achieve its full year total revenue growth target of 4-5%. The household goods group also announced that it is planning to hive off its drug arm into a separate UK-listed company. Aberdeen Asset Management reported a pick-up in business in Asia and emerging markets, but revealed a slight fall in assets under management. Assets under management at June 30th totalled £322.5bn, down 0.6% on the £324.5m at the end of March 2014. Analysts at Credit Suisse upped their price target on shares of RBS to 310p from 280p previously, but retained their 'underperform' rating. The lender is progressing better than expected on the run-down of the assets of its non-core RBS Capital Resolution (RCR) arm, but its valuation already captures the "steady state" profile of returns which can be expected, according to the broker. A breakup of GlaxoSmithKline is a possibility as a result of a sweeping overhaul of the group, according to the Chief Executive of the pharmaceuticals giant, the Financial Times said. Budget airline Ryanair more than doubled its first quarter profit and said it was raising annual profit expectations, but warned of second-half pressure on fares from rival price-cutting. Ryanair said first quarter net profit rose 152% to €197m versus the same time a year ago due partly to a strong Easter, but cautioned that it compared with no holiday in the same period last time.Randgold Resources said it was focusing on its Tongon gold mine in Côte d'Ivoire where it is "continuing to make headway" in its efforts to overcome the technical issues that have affected its performance. Chief Executive Mark Bristow admitted this year's planned ramp-up in production had not been achieved due to the need to expand the flotation circuit and the mechanical failure of the recently installed Vibrocone crushers, intended to improve the recovery and throughput rate. National Grid reported a continued "solid operational and financial performance" between April 1st and July 27th, with the UK delivering operational efficiencies and progress with its investment programme, while the US saw a good operational performance.FTSE 100 - RisersBritish Sky Broadcasting Group (BSY) 904.50p +3.43%Reckitt Benckiser Group (RB.) 5,205.00p +2.66%Fresnillo (FRES) 940.00p +2.12%Pearson (PSON) 1,153.00p +1.86%HSBC Holdings (HSBA) 630.90p +1.48%Aggreko (AGK) 1,757.00p +1.15%BG Group (BG.) 1,212.00p +1.08%Randgold Resources Ltd. (RRS) 5,170.00p +1.08%Centrica (CNA) 315.20p +0.93%National Grid (NG.) 879.00p +0.92%FTSE 100 - FallersAberdeen Asset Management (ADN) 435.00p -5.31%Royal Bank of Scotland Group (RBS) 352.00p -3.35%Kingfisher (KGF) 295.80p -2.89%Royal Mail (RMG) 430.00p -2.52%Smith & Nephew (SN.) 1,033.00p -2.27%Hargreaves Lansdown (HL.) 1,047.00p -1.97%ARM Holdings (ARM) 846.00p -1.86%Meggitt (MGGT) 517.50p -1.62%Glencore (GLEN) 371.95p -1.47%IMI (IMI) 1,412.00p -1.40%FTSE 250 - RisersOphir Energy (OPHR) 207.10p +4.23%Debenhams (DEB) 66.20p +3.28%Infinis Energy (INFI) 239.10p +2.97%Drax Group (DRX) 686.50p +2.69%Petra Diamonds Ltd.(DI) (PDL) 216.60p +2.65%Exova Group (EXO) 240.00p +2.13%Restaurant Group (RTN) 610.00p +2.09%Rightmove (RMV) 2,208.00p +1.75%BH Global Ltd. USD Shares (BHGU) 11.99 +1.61%Fidelity China Special Situations (FCSS) 110.90p +1.37%FTSE 250 - FallersPets at Home Group (PETS) 170.10p -7.05%AO World (AO.) 200.00p -5.70%Xaar (XAR) 543.00p -4.65%CSR (CSR) 555.00p -4.47%Pace (PIC) 355.00p -3.64%JD Sports Fashion (JD.) 386.00p -3.45%Fidessa Group (FDSA) 2,055.00p -3.38%Howden Joinery Group (HWDN) 336.40p -3.19%Evraz (EVR) 95.00p -3.16%Ted Baker (TED) 1,685.00p -3.16%FTSE TechMARK - RisersOxford Biomedica (OXB) 2.92p +2.63%Sarossa (SARS) 1.93p +1.32%Gresham Computing (GHT) 127.00p +0.79%BATM Advanced Communications Ltd. (BVC) 17.00p +0.74%CML Microsystems (CML) 365.00p +0.69%XP Power Ltd. (DI) (XPP) 1,500.00p +0.67%RM (RM.) 165.00p +0.61%Kofax Limited (DI) (KFX) 420.00p +0.36%Skyepharma (SKP) 246.00p +0.10%IShares Euro Gov Bond 7-10YR UCITS ETF (IEGM) € 193.06 +0.09%FTSE TechMARK - FallersElectronic Data Processing (EDP) 72.50p -2.68%Torotrak (TRK) 18.75p -1.96%Vectura Group (VEC) 140.00p -1.93%Dialight (DIA) 939.50p -1.88%Optos (OPTS) 186.00p -1.85%E2V Technologies (E2V) 154.00p -1.75%Promethean World (PRW) 31.00p -1.59%Puricore (PURI) 35.50p -1.39%Anite (AIE) 90.25p -1.37%KCOM Group (KCOM) 93.50p -1.32%AB
More News
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.